Immunotherapy outcomes in metastatic melanoma at KFSHRC
Retrospective analysis of pembrolizumab and nivolumab outcomes in stage IV melanoma patients treated at KFSHRC over the past 4 years.
Every project below is supervised by a faculty oncologist at King Faisal Specialist Hospital & Research Centre, our primary collaborator. Filter by one of our four core disciplines, then apply to projects that match your interests.
Retrospective analysis of pembrolizumab and nivolumab outcomes in stage IV melanoma patients treated at KFSHRC over the past 4 years.
Retrospective analysis using RNA-seq data from TNBC patients. Looking for help with literature review and basic statistical analysis.
Retrospective study examining survival and toxicity outcomes in stage I non-small cell lung cancer patients treated with stereotactic body radiotherapy.
Dosimetric comparison study evaluating intensity-modulated vs volumetric modulated arc therapy plans for oropharyngeal carcinomas.
PRISMA-compliant systematic review and meta-analysis of CAR-T cell therapy outcomes in adult patients with relapsed/refractory B-cell lymphomas.
Cross-sectional study assessing cardiac, endocrine, and neurocognitive late effects in children who completed treatment for ALL 5+ years ago.
Protocol development and outcome evaluation for opioid stewardship and palliative interventions in stage IV pancreatic adenocarcinoma.
Survey-based study evaluating QoL metrics across different chemotherapy regimens for stage IV colorectal cancer. Patient interview experience preferred.
Submit your profile anyway — we'll match you with new projects as faculty post them. Most spots are filled within 2 weeks of opening.